GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » GENinCode PLC (LSE:GENI) » Definitions » Pretax Margin %

GENinCode (LSE:GENI) Pretax Margin % : -175.45% (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is GENinCode Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. GENinCode's Pre-Tax Income for the six months ended in Jun. 2024 was £-2.44 Mil. GENinCode's Revenue for the six months ended in Jun. 2024 was £1.39 Mil. Therefore, GENinCode's pretax margin for the quarter that ended in Jun. 2024 was -175.45%.

The historical rank and industry rank for GENinCode's Pretax Margin % or its related term are showing as below:

LSE:GENI' s Pretax Margin % Range Over the Past 10 Years
Min: -401.82   Med: -341.78   Max: -109.26
Current: -229.05


LSE:GENI's Pretax Margin % is ranked worse than
85.51% of 214 companies
in the Medical Diagnostics & Research industry
Industry Median: -6.72 vs LSE:GENI: -229.05

GENinCode Pretax Margin % Historical Data

The historical data trend for GENinCode's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GENinCode Pretax Margin % Chart

GENinCode Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Pretax Margin %
- -109.26 -358.41 -401.82 -325.14

GENinCode Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only -350.00 -446.74 -369.16 -290.58 -175.45

Competitive Comparison of GENinCode's Pretax Margin %

For the Diagnostics & Research subindustry, GENinCode's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GENinCode's Pretax Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, GENinCode's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where GENinCode's Pretax Margin % falls into.


;
;

GENinCode Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

GENinCode's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-7.023/2.16
=-325.14 %

GENinCode's Pretax Margin for the quarter that ended in Jun. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=-2.437/1.389
=-175.45 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GENinCode  (LSE:GENI) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


GENinCode Pretax Margin % Related Terms

Thank you for viewing the detailed overview of GENinCode's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


GENinCode Business Description

Traded in Other Exchanges
N/A
Address
Oxford Science Park, John Eccles House, Robert Robertson Avenue, Oxford, GBR, OX4 4GP
GENinCode PLC is engaged in the genetic risk assessment, prediction, and prevention of cardiovascular diseases including coronary artery diseases such as angina and myocardial infarction (heart attack), stroke, heart failure, hypertension, and other vascular heart diseases. The company's current product portfolio comprises Cardio inCode, LiPID inCode, SuDD inCode, and Thrombo inCode. The company has only one reportable segment the sale of kits and the provision of support services. The Geographic Markets of the group are Chile, France, Italy, Sweden, Mexico, Spain, and the United Kingdom.